Skip to main content
Clinical Trials/NL-OMON27513
NL-OMON27513
Recruiting
Not Applicable

Smartphone based Monitoring and cognition Modification Against Recurrence of Depression – Workpackage 2

Radboudumc0 sites120 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
(Remitted) Major Depressive Disorder
Sponsor
Radboudumc
Enrollment
120
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Radboudumc

Eligibility Criteria

Inclusion Criteria

  • 1\.Age 18\-65 years
  • 2\.Recurrent MDD diagnoses (according to DSM\-IV and SCID)
  • 3\.At least 3 previous MDD\-episodes (assessed with the SCID\-interview)
  • 4\.In stable remission: does not meet criteria for a current MDD episode (SCID\-interview) \=8 weeks and a Hamilton Depression Rating Scale score \=10
  • 5\.In possession of smartphone and experienced in use thereof

Exclusion Criteria

  • 1\.Diagnosis of bipolar, primary psychotic or borderline personality disorder or strong suspicion of this type of disorder
  • 2\.Primary diagnosis of substance use or anxiety disorder with secondary MDD
  • 3\.Electroconvulsive therapy within two months before inclusion
  • 4\.Average alcohol intake of \>3 units/day
  • 5\.Daily use of benzodiazepines (\=5mg diazepam or equivalent)
  • 6\.Ongoing psychotherapy during the CCT/ABT/MBT training
  • 7\.Previous CCT/AB/MBT training
  • For the optional add\-on MRI\-part, standard MRI exclusion criteria will apply.

Outcomes

Primary Outcomes

Not specified

Similar Trials